TGIF1 and central nervous system cancer: in order to try to find more evidence to confirm that TGIF1 is a pathogenic molecule for the prognosis of patients with glioma, the study used a meta‐analysis to find that each data showed that TGIF1 was a risk for the prognosis of patients in seven independent datasets and the pooled HR for the association between TGIF1 expression and OS in patients was 1.61 (1.32–1.96).